Head Of Biomarkers For Chronic Kidney Disease And Acute Kidney Injury
CurrentResponsible for managing biomarker and translational strategies in metabolic disease, chronic kidney disease, and acute kidney injury. Member of program teams and Compound Development Teams and support early clinical development strategy. Responsible for leading multiple collaborations with academic investigators and external companies in support of biomarker and translational research. Responsible for the development program specific biomarker strategies including identification and validation of assays and coordination of best practices. Responsible for the application of genomic, proteomic and metabolomic technologies for identification and development of novel biomarkers to enable the clinical development of the right drugs, at the right dose, for the right patients. Responsible/accountable for leading matrix teams and deliverables.